Eli Lilly’s weight-loss drug reduces risk of developing diabetes in long-term trial
In a recent long-term research study published Tuesday, Eli Lilly reported that its popular weight-management drug significantly reduced the incidence of type 2 diabetes by 94 percent among overweight or…